Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride

Arzneimittelforschung

Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,286 · see citing works

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · see citing works

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · cited 2× · see citing works

Increased baseline occupancy of D ₂ receptors by dopamine in schizophrenia

Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020 · see citing works

Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease

de la Fuente‐Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., & Stoessl, A. J. (2001) · Science · doi:10.1126/science.1060937 · Cited by 991 · see citing works

Imaging Synaptic Neurotransmission with <i>in Vivo</i> Binding Competition Techniques: A Critical Review

Laruelle, M. (2000) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944 · see citing works

Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics

Wong, D. F., Wagner, H. N., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E., Ravert, H. T., Wilson, A. A., et al. (1986) · Science · doi:10.1126/science.2878495 · Cited by 928 · see citing works

Linearized Reference Tissue Parametric Imaging Methods: Application to [ 11 C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain

Ichise, M., Liow, J., Lu, J., Takano, A., Modell, K. J., Toyama, H., Suhara, T., Suzuki, K., Innis, R. B., & Carson, R. E. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000085441.37552.ca · Cited by 651 · see citing works

The ECAT EXACT HR

Wienhard, K., Dahlbom, M. L., Eriksson, L., Michel, C. J., Bruckbauer, T., Pietrzyk, U., & Heiss, W. (1994) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199401000-00023 · Cited by 561 · see citing works

D2 Dopamine Receptors in Neuroleptic-Naive Schizophrenic Patients

Farde, L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150013003 · Cited by 529 · see citing works

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine

Verma, A., & Moghaddam, B. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00373.1996 · Cited by 449 · see citing works

Imaging endogenous dopamine competition with [¹¹C]raclopride in the human brain

Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379 · see citing works

SPECT imaging of striatal dopamine release after amphetamine challenge.

Laruelle, M. A., Abi‐Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., & Kung, H. F. (1995) · PubMed · Cited by 333 · see citing works

No D2 Receptor Increase in PET Study of Schizophrenia

Farde, L. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190091013 · Cited by 293 · see citing works

Dopamine D2 Receptor Dimers and Receptor-Blocking Peptides

Ng, G., O’Dowd, B. F., Lee, S. P., Chung, H. T.-K., Brann, M. R., Seeman, P. M., & George, S. R. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1489 · Cited by 273 · see citing works

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

Laruelle, M. A., Iyer, R. N., Al‐Tikriti, M. S., Zea‐Ponce, Y., Malison, R. T., Zoghbi, S. S., Baldwin, R. M., Kung, H. F., Charney, D. S., Hoffer, P. B., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199701)25:1 · Cited by 264 · see citing works

Quantification of Amphetamine-Induced Changes in [ 11 C]Raclopride Binding with Continuous Infusion

Carson, R. E., Breier, A. F., de Bartolomeis, A., Saunders, R. C., Su, T., Schmall, B., Der, M. G., Pickar, D., & Eckelman, W. C. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199704000-00009 · Cited by 237 · see citing works

Radiosynthesis and Evaluation of [11C]-(+)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a Potential Radiotracer for in Vivo Imaging of the Dopamine D2 High-Affinity State with Positron Emission Tomography

Wilson, A. A., McCormick, P. N., Kapur, S., Willeit, M., García, A., Hussey, D. F., Houle, S., Seeman, P. M., & Ginovart, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050155n · Cited by 227 · see citing works

Expression and pharmacological characterization of the human D3 dopamine receptor.

Freedman, S. B., Patel, S., Marwood, R., Emms, F., Seabrook, G. R., Knowles, M. R., & McAllister, G. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38490-9 · Cited by 224 · see citing works

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans

Vollenweider, F. X., Vontobel, P., Øye, I., Hell, D., & Leenders, K. L. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00031-x · Cited by 223 · see citing works

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S. S., Seibyl, J. P., Charney, D. S., & Innis, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1108 · Cited by 222 · see citing works

Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects

G Smith, P. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00092-4 · Cited by 201 · see citing works

A JAVA environment for medical image data analysis: Initial application for brain PET quantitation

Mikolajczyk, K. P., Szabatin, M., Rudnicki, P., Grodzki, M., & Burger, C. (1998) · Medical Informatics · doi:10.3109/14639239809001400 · Cited by 179 · see citing works

The Functional State of the Dopamine Receptor in the Anterior Pituitary Is in the High Affinity Form*

George, S. R., Watanabe, M., Paolo, T. D., Falardeau, P., Labrie, F., & Seeman, P. M. (1985) · Endocrinology · doi:10.1210/endo-117-2-690 · Cited by 171 · see citing works

Levodopa‐induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET

Tedroff, J., Pedersen, M., Sm, A., Hartvig, P., Jacobsson, G., & Långström, B. (1996) · Neurology · doi:10.1212/wnl.46.5.1430 · Cited by 162 · see citing works

In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride

Narendran, R., Hwang, D., Slifstein, M., Talbot, P., Erritzoe, D., Huang, Y., Cooper, T. B., Martinez, D., Kegeles, L. S., Abi-Dargham, A., et al. (2004) · Synapse · doi:10.1002/syn.20013 · Cited by 156 · see citing works

Amphetamine‐stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates

Innis, R. B., Malison, R. T., Al‐Tikriti, M. S., Hoffer, P. B., Sybirska, E. H., Seibyl, J. P., Zoghbi, S. S., Baldwin, R. M., Laruelle, M. A., Smith, E. O., et al. (1992) · Synapse · doi:10.1002/syn.890100302 · Cited by 155 · see citing works

Dopamine D2 receptor binding sites for agonists. A tetrahedral model.

Seeman, P. M., Watanabe, M., Grigoriadis, D. E., Tedesco, J. L., George, S. R., Svensson, U. S. H., Nilsson, J., & Neumeyer, J. L. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14176-x · Cited by 135 · see citing works

Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression

Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01089-7 · Cited by 133 · see citing works

PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor

Karlsson, P., Farde, L., Halldin, C., Swahn, C., Sedvall, G., Foged, C., Hansen, K. T., & Skrumsager, B. K. (1993) · Psychopharmacology · doi:10.1007/bf02245691 · Cited by 130 · see citing works

Dopamine D2 receptor dimers in human and rat brain

Zawarynski, P., Tallerico, T., Seeman, P. M., Lee, S. P., O’Dowd, B. F., & George, S. R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01588-9 · Cited by 123 · see citing works

Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand [11C]raclopride from [11C]methyl triflate

Langer, O., Någren, K., Dollé, F., Lundkvist, C., Sandell, J., Swahn, C., Vaufrey, F., Crouzel, C., Maziere, B., & Halldin, C. (1999) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/(sici)1099-1344(199912)42:12 · Cited by 116 · see citing works

NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans

Kegeles, L., Martinez, D., Kochan, L., Hwang, D., Huang, Y., Mawlawi, O., Suckow, R., Heertum, R. V. V., & Laruelle, M. (2002) · Synapse · doi:10.1002/syn.10010 · Cited by 106 · see citing works

Effect of reserpine-induced depletion of synaptic dopamine on [11C]Raclopride binding to D2-dopamine receptors in the monkey brain

Ginovart, N., Farde, L., Halldin, C., & Swahn, C. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199704)25:4 · Cited by 105 · see citing works

A Simple Method to Measure Baseline Occupancy of Neostriatal Dopamine D2 Receptors by Dopamine In Vivo in Healthy Subjects

Verhoeff, N., Kapur, S., Hussey, D., Lee, M., Christensen, B., Psych, C., Papatheodorou, G., & Zipursky, R. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00231-7 · Cited by 86 · see citing works

A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.

Finnema, S., Seneca, N., Farde, L., Shchukin, E., Sóvágó, J., Gulyás, B., Wikström, H., Innis, R., Neumeyer, J., & Halldin, C. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.01.007 · Cited by 86 · see citing works

Regulation of ligand binding to pituitary D-2 dopaminergic receptors. Effects of divalent cations and functional group modification.

Sibley, D. R., & Creese, I. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32521-3 · Cited by 78 · see citing works

PET study of the [ 11 C]raclopride binding in the striatum of the awake cat: effects of anaesthetics and role of cerebral blood flow

Saba, W., Cavorsin, M. L., Ginovart, N., Zimmer, L., Gualda, V., Bonnefoi, F., & Leviel, V. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0904-4 · Cited by 74 · see citing works

Specific Binding of [ ¹¹ C]Raclopride and <i>N</i> -[ ³ H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G Protein

Cumming, P., Wong, D. F., Gillings, N., Hilton, J., Scheffel, U., & Gjedde, A. (2002) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1097/00004647-200205000-00011 · Cited by 71 · see citing works

Ketamine does not decrease striatal dopamine D 2 receptor binding in man

Aalto, S., Hirvonen, J., Kajander, J., Scheinin, H., Någren, K., Vilkman, H., Gustafsson, L. L., Syvälahti, E. K. G., & Hietala, J. A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1236-6 · Cited by 69 · see citing works

Anesthetics inhibit high‐affinity states of dopamine D2 and other G‐linked receptors

Seeman, P. M., & Kapur, S. (2003) · Synapse · doi:10.1002/syn.10221 · Cited by 68 · see citing works

NMDA antagonist effects on striatal dopamine release: Microdialysis studies in awake monkeys

Adams, B. W., Bradberry, C., & Moghaddam, B. (2002) · Synapse · doi:10.1002/syn.1114 · Cited by 65 · see citing works

In vivo assessment of basal and drug‐induced dopamine release in cortical and subcortical regions of the anesthetized primate

Moghaddam, B., Berridge, C. W., Goldman‐Rakic, P. S., Bunney, B. S., & Roth, R. H. (1993) · Synapse · doi:10.1002/syn.890130304 · Cited by 64 · see citing works

Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.

Sibley, D. R., Mahan, L. C., & Creese, I. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14291-0 · Cited by 64 · see citing works

Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogs

Gao, Y., Baldessarini, R. J., Kula, N. S., & Neumeyer, J. L. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00168a040 · Cited by 60 · see citing works

Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors

Köhler, C., Fuxé, K., & Ross, S. B. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90584-7 · Cited by 52 · see citing works

In vivo binding of N-n-propylnorapomorphine in the rat brain: Regional localization, quantification in striatum and lack of correlation with dopamine metabolism

van der Werf, J. F., Sebens, J. B., Vaalburg, W., & Korf, J. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90336-9 · Cited by 52 · see citing works

Kinetic properties of the in vivo accumulation of 3H-(?)-N-n-propylnorapomorphine in mouse brain

Ross, S., & Jackson, D. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169200 · Cited by 51 · see citing works

Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist

Neumeyer, J. L., Gao, Y., Kula, N. S., & Baldessarini, R. J. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00174a002 · Cited by 45 · see citing works

Agonist interactions with dopamine receptors: focus on radioligand-binding studies.

Creese, I., Sibley, D. R., & Leff, S. E. (1984) · PubMed · Cited by 40 · see citing works

Kinetics of the uptake and distribution of the dopamine D2,3 agonist (R)-N-[1-11C]n-propylnorapomorphine in brain of healthy and MPTP-treated Göttingen miniature pigs

Cumming, P. D., Gillings, N., Jensen, S. B., Bjarkam, C. R., & GJEDDE, A. H. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00448-1 · Cited by 31 · see citing works

Binding characteristics of high‐affinity dopamine D2/D3 receptor agonists, 11C‐PPHT and 11C‐ZYY‐339 in rodents and imaging in non‐human primates by PET

Mukherjee, J., Narayanan, T. K., Christian, B., Shi, B., & Yang, Z.-Y. (2004) · Synapse · doi:10.1002/syn.20068 · Cited by 25 · see citing works

Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5′-18F-fluoropentyl)aminotetralin (18F-5-OH-FPPAT) in rodents and nonhuman primates

Shi, B., Narayanan, T. K., Christian, B., Chattopadhyay, S., & Mukherjee, J. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2003.10.004 · Cited by 23 · see citing works

Positron-Labeled Dopamine Agonists for Probing the High Affinity States of Dopamine Subtype 2 Receptors

Hwang, D., Narendran, R., & Laruelle, M. A. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049834n · Cited by 23 · see citing works

Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.

Farde, L., & Hall, H. (1992) · PubMed · Cited by 11 · see citing works

Scatchard Analysis of the D2 Receptor Agonist [C-11]MNPA in the Monkey Brain Using PET

Finnema, S. J., Seneca, N. M., Farde, L., Gulyás, B. Z., Bang‐Andersen, B., Wikström, H., Innis, R. B., & Halldin, C. (n.d.) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 3 · see citing works

Untitled work

Andersen (2000) · doi:10.1002/1098-2396(200008)37:2

The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities

Faraone, S. V. (2018) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631 · see citing works

All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors

Seeman, P. (2011) · CNS Neuroscience &amp; Therapeutics · doi:10.1111/j.1755-5949.2010.00162.x · Cited by 228 · see citing works

Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging

Pike, V. W. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160418114826 · Cited by 197 · see citing works

Dopamine D2 Receptors as Treatment Targets in Schizophrenia

Seeman, P. M. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.1.5 · Cited by 193 · see citing works

Using positron emission tomography to facilitate CNS drug development

Lee, C., & Farde, L. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.04.004 · Cited by 169 · see citing works

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo

Narendran, R., Slifstein, M., Guillin, O., Hwang, Y., Hwang, D., Scher, E., Reeder, S., Rabiner, E. A., & Laruelle, M. A. (2006) · Synapse · doi:10.1002/syn.20325 · Cited by 167 · see citing works

Target site occupancy: emerging generalizations from clinical and preclinical studies.

Grimwood, S., & Hartig, P. (2009) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2009.03.002 · Cited by 124 · see citing works

The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study

Graff‐Guerrero, A., Mizrahi, R., Agid, O., Marcon, H., Barsoum, P., Rusjan, P., Wilson, A. A., Zipursky, R. B., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.199 · Cited by 108 · see citing works

First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: a [11C]-(+)-PHNO positron emission tomography study

Willeit, M., Ginovart, N., Graff, A., Rusjan, P., Vitcu, I., Houle, S., Seeman, P., Wilson, A. A., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301400 · Cited by 107 · see citing works

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease

Boileau, I., Guttman, M., Rusjan, P., Adams, J. R., Houle, S., Tong, J., Hornykiewicz, O., Furukawa, Y., Wilson, A. A., Kapur, S., et al. (2009) · Brain · doi:10.1093/brain/awn337 · Cited by 106 · see citing works

Volume transmission and its different forms in the central nervous system

Fuxé, K., Borroto‐Escuela, D. O., Romero‐Fernandez, W., Zhang, W., & Agnati, L. F. (2013) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-013-1455-1 · Cited by 96 · see citing works

D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model

Skinbjerg, M., Liow, J.-S., Seneca, N., Hong, J., Lu, S., Thorsell, A., Heilig, M., Pike, V. W., Halldin, C., Sibley, D. R., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.055 · Cited by 86 · see citing works

On the role of volume transmission and receptor-receptor interactions in social behaviour: focus on central catecholamine and oxytocin neurons

Fuxe, K., Borroto-Escuela, D. O., Romero-Fernandez, W., Ciruela, F., Manger, P., Leo, G., Díaz-Cabiale, Z., & Agnati, L. F. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.062 · Cited by 81 · see citing works

Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism

Vauquelin, G., Bostoen, S., Vanderheyden, P., & Seeman, P. M. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0734-2 · Cited by 80 · see citing works

Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum

Červenka, S., Bäckman, L., Cselényi, Z., Halldin, C., & Farde, L. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.063 · Cited by 80 · see citing works

Application of cross-species PET imaging to assess neurotransmitter release in brain

Finnema, S., Scheinin, M., Shahid, M., Lehto, J., Borroni, E., Bang-Andersen, B., Sallinen, J., Wong, E. H. F., Farde, L., Halldin, C., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3938-6 · Cited by 69 · see citing works

A Comparative Evaluation of the Dopamine D2/3 Agonist Radiotracer [11C](−)-N-Propyl-norapomorphine and Antagonist [11C]Raclopride to Measure Amphetamine-Induced Dopamine Release in the Human Striatum

Narendran, R., Mason, N. S., Laymon, C. M., Lopresti, B. J., Velasquez, N. D., May, M. A., Kendro, S., Martínez, D., Mathis, C. A., & Frankle, W. G. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163501 · Cited by 77 · see citing works

Extrasynaptic Neurotransmission in the Modulation of Brain Function. Focus on the Striatal Neuronal–Glial Networks

Fuxé, K., Borroto‐Escuela, D. O., Romero‐Fernandez, W., Dı́az-Cabiale, Z., Rivera, A., Ferraro, L., Tanganelli, S., Tarakanov, A. O., Garriga, P., Narváez, J. Á., et al. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00136 · Cited by 73 · see citing works

Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain

Finnema, S. J., Stepanov, V., Ettrup, A., Nakao, R., Amini, N., Svedberg, M., Lehmann, C., Hansen, M., Knudsen, G. M., & Halldin, C. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.035 · Cited by 72 · see citing works

Increased affinity of dopamine for D2‐like versus D1‐like receptors. Relevance for volume transmission in interpreting PET findings

Marcellino, D. J., Kehr, J., Agnati, L. F., & Fuxé, K. (2011) · Synapse · doi:10.1002/syn.21501 · Cited by 61 · see citing works

Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors

Borroto‐Escuela, D. O., de la Mora, M. P., Manger, P. R., Narváez, M., Beggiato, S., Crespo‐Ramírez, M., Navarro, G., Wydra, K., Dı́az-Cabiale, Z., Rivera, A., et al. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00020 · Cited by 61 · see citing works

Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review

Cumming, P. D. (2011) · Synapse · doi:10.1002/syn.20916 · Cited by 59 · see citing works

In Vivo Imaging of Cerebral Dopamine D3 Receptors in Alcoholism

Erritzøe, D., Tziortzi, A. C., Bargiela, D., Colasanti, A., Searle, G. E., Gunn, R. N., Beaver, J. D., Waldman, A. D., Nutt, D., Bani, M., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.18 · Cited by 58 · see citing works

Imaging the high-affinity state of the dopamine D2 receptor in vivo: Fact or fiction?

Skinbjerg, M., Sibley, D., Javitch, J., & Abi-Dargham, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.008 · Cited by 63 · see citing works

Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning

Karabanov, A. N., Červenka, S., de Manzano, Ö., Forssberg, H., Farde, L., & Ullén, F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911805107 · Cited by 54 · see citing works

The Dopamine Hypothesis of Schizophrenia

Gründer, G., & Cumming, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00015-x · Cited by 6 · see citing works

Imaging neurotransmitter release by drugs of abuse.

Martinez, D., & Narendran, R. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_34 · Cited by 42 · see citing works

Recent advances in PET imaging for evaluation of Parkinson’s disease

Sioka, C., FOTOPOULOS, A. D., & Kyritsis, A. P. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1357-9 · Cited by 46 · see citing works

Dopamine D2 receptor radiotracers [11C](+)-PHNO and [3H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo

McCormick, P. N., Kapur, S., Seeman, P. M., & Wilson, A. A. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.08.005 · Cited by 45 · see citing works

Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

Colom, M., Vidal, B., & Zimmer, L. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00255 · Cited by 44 · see citing works

Measuring Dopamine Synaptic Transmission with Molecular Imaging and Pharmacological Challenges: The State of the Art

Laruelle, M. (2012) · Neuromethods · doi:10.1007/7657_2012_45 · Cited by 40 · see citing works

Imaging in Vivo Glutamate Fluctuations with [ 11 C]ABP688: A GLT-1 Challenge with Ceftriaxone

Zimmer, E. R., Parent, M. J., Leuzy, A., Aliaga, A., Aliaga, A., Moquin, L., Schirrmacher, E. S., Soucy, J., Skelin, I., Gratton, A. P., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.35 · Cited by 42 · see citing works

Test–Retest Reproducibility of Binding Parameters in Humans with 11C-LY2795050, an Antagonist PET Radiotracer for the κ Opioid Receptor

Naganawa, M., Zheng, M., Henry, S. E., Nabulsi, N., Lin, S.-F., Ropchan, J. R., Labaree, D. C., Najafzadeh, S., Kapinos, M., Tauscher, J. T., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.147975 · Cited by 41 · see citing works

Dopamine D₂ and D₃ binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task

Suridjan, I., Rusjan, P., Addington, J., Wilson, A. A., Houle, S., & Mizrahi, R. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110181 · Cited by 38 · see citing works

In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD

Leuzy, A., Zimmer, E., DuBois, J., Pruessner, J., Cooperman, C., Soucy, J., Kostikov, A., Schirmaccher, E., Désautels, R., Gauthier, S., et al. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0978-3 · Cited by 38 · see citing works

Agonist high- and low-affinity states of dopamine D2 receptors: methods of detection and clinical implications

van Wieringen, J., Booij, J., Shalgunov, V., Elsinga, P., & Michel, M. (2012) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-012-0817-0 · Cited by 40 · see citing works

[N-methyl-3H3]AZ10419369 Binding to the 5-HT1B Receptor: In Vitro Characterization and in Vivo Receptor Occupancy

Maier, D. L., Sobotka-Briner, C., Ding, M., Powell, M. E., Jiang, Q., Hill, G. R., Heys, J. R., Elmore, C. S., Pierson, M. E., & Mrzljak, L. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.150722 · Cited by 36 · see citing works

Dopamine D2Highreceptors measured ex vivo are elevated in amphetamine‐sensitized animals

Seeman, P. M. (2008) · Synapse · doi:10.1002/syn.20595 · Cited by 35 · see citing works

Pharmacological characterization of 2‐methoxy‐N‐propylnorapomorphine's interactions with D2and D3dopamine receptors

Skinbjerg, M., Namkung, Y., Halldin, C., Innis, R. B., & Sibley, D. R. (2009) · Synapse · doi:10.1002/syn.20626 · Cited by 33 · see citing works

Dopamine D2/3receptor occupancy of apomorphine in the nonhuman primate brain—A comparative PET study with [11C]raclopride and [11C]MNPA

Finnema, S. J., Halldin, C., Bang‐Andersen, B., Gulyás, B. Z., Bundgaard, C., Wikström, H., & Farde, L. (2009) · Synapse · doi:10.1002/syn.20615 · Cited by 33 · see citing works

Neuroimaging and Physiological Evidence for Involvement of Glutamatergic Transmission in Regulation of the Striatal Dopaminergic System

Tokunaga, M., Seneca, N. M., Shin, R.-M., Maeda, J., Obayashi, S., Okauchi, T., Nagai, Y., Zhang, M., Nakao, R., Ito, H., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2559-08.2009 · Cited by 33 · see citing works

Positron Emission Tomography Imaging Demonstrates Correlation between Behavioral Recovery and Correction of Dopamine Neurotransmission after Gene Therapy

Leriche, L., Björklund, T., Breysse, N., Besret, L., Grégoire, M., Carlsson, T., Dollé, F., Mandel, R. J., Déglon, N., Hantraye, P., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4491-08.2009 · Cited by 33 · see citing works

Binding of Pramipexole to Extrastriatal Dopamine D2/D3 Receptors in the Human Brain: A Positron Emission Tomography Study Using 11C-FLB 457

Ishibashi, K., Ishii, K., Oda, K., Mizusawa, H., & Ishiwata, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017723 · Cited by 32 · see citing works

Neuroimaging and drug taking in primates

Murnane, K. S., & Howell, L. L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2222-7 · Cited by 32 · see citing works

Isoflurane Anaesthesia Differentially Affects the Amphetamine Sensitivity of Agonist and Antagonist D2/D3 Positron Emission Tomography Radiotracers: Implications for In Vivo Imaging of Dopamine Release

McCormick, P. N., Ginovart, N., & Wilson, A. A. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0380-3 · Cited by 30 · see citing works

Nonhuman Primate Positron Emission Tomography Neuroimaging in Drug Abuse Research

Howell, L. L., & Murnane, K. S. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136689 · Cited by 29 · see citing works

Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain

Yang, K.-C., Stepanov, V., Martinsson, S., Ettrup, A., Takano, A., Knudsen, G., Halldin, C., Farde, L., & Finnema, S. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx051 · Cited by 26 · see citing works

Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds

Andersson, J. D., Pierson, M. E., Finnema, S. J., Gulyás, B. Z., Heys, R., Elmore, C. S., Farde, L., & Halldin, C. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.08.006 · Cited by 27 · see citing works

Brain Imaging in Nonhuman Primates: Insights into Drug Addiction

Nader, M. A., & Czoty, P. W. (2008) · ILAR Journal · doi:10.1093/ilar.49.1.89 · Cited by 27 · see citing works

Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA

Seneca, N. M., Zoghbi, S. S., Skinbjerg, M., Liow, J., Hong, J. S., Sibley, D. R., Pike, V. W., Halldin, C., & Innis, R. B. (2008) · Synapse · doi:10.1002/syn.20549 · Cited by 26 · see citing works

Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride

Kodaka, F., Ito, H., Kimura, Y., Fujie, S., Takano, H., Fujiwara, H., Sasaki, T., Nakayama, K., Halldin, C., Farde, L., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2312-8 · Cited by 25 · see citing works

Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia

Kubota, M., Nagashima, T., Takano, H., Kodaka, F., Fujiwara, H., Takahata, K., Moriguchi, S., Kimura, Y., Higuchi, M., Okubo, Y., et al. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx063 · Cited by 25 · see citing works

Dopamine D3 Receptors Are Down-regulated following Heterologous Endocytosis by a Specific Interaction with G Protein-coupled Receptor-associated Sorting Protein-1

Thompson, D., & Whistler, J. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158345 · Cited by 25 · see citing works

Understanding the balance and integration of volume and synaptic transmission. Relevance for psychiatry

Fuxé, K., Borroto‐Escuela, D. O., Tarakanov, A. O., Romero‐Fernandez, W., Manger, P. R., Rivera, A., Craenenbroeck, K. V., Skieterska, K., Dı́az-Cabiale, Z., Filip, M., et al. (2013) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2013.10.002 · Cited by 25 · see citing works

Hunting for the high‐affinity state of G‐protein‐coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging

Shalgunov, V., van Waarde, A., Booij, J., Michel, M. C., Dierckx, R., & Elsinga, P. H. (2018) · Medicinal Research Reviews · doi:10.1002/med.21552 · Cited by 24 · see citing works

18F-MCL-524, an18F-Labeled Dopamine D2and D3Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study

Finnema, S. J., Stepanov, V. A., Nakao, R., Sromek, A. W., Zhang, T., Neumeyer, J. L., George, S. R., Seeman, P. M., Stabin, M. G., Jonsson, C., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.133876 · Cited by 23 · see citing works

Ex vivo [11C]‐(+)‐PHNO binding is unchanged in animal models displaying increased high‐affinity states of the D2receptor in vitro

McCormick, P. N., Kapur, S., Reckless, G. E., & Wilson, A. A. (2009) · Synapse · doi:10.1002/syn.20671 · Cited by 23 · see citing works

In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography

Takamura, Y., & Kakuta, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01714 · Cited by 22 · see citing works

The Discovery and Development of Pharmacotherapy for Psychiatric Disorders: A Critical Survey of Animal and Translational Models and Perspectives for Their Improvement

Millan, M. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00001-1 · Cited by 22 · see citing works

Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity

Nikolaus, S., Wittsack, H., Beu, M., Antke, C., Hautzel, H., Wickrath, F., Müller‐Lutz, A., Silva, M. A. D. S., Huston, J. P., Antoch, G., et al. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.010 · Cited by 21 · see citing works

Further evaluation of the carbon11‐labeled D2/3agonist PET radiotracer PHNO: Reproducibility in tracer characteristics and characterization of extrastriatal binding

Egerton, A., Hirani, E., Ahmad, R., Turton, D. R., Bričkutė, D., Rosso, L., Howes, O. D., Luthra, S. K., & Grasby, P. M. (2009) · Synapse · doi:10.1002/syn.20718 · Cited by 20 · see citing works

Ketamine/xylazine anesthesia alters [11C]MNPA binding to dopamine D2receptors and response to methamphetamine challenge in monkey brain

Ohba, H., Harada, N., Nishiyama, S., Kakiuchi, T., & Tsukada, H. (2009) · Synapse · doi:10.1002/syn.20632 · Cited by 20 · see citing works

Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia

Zhou, X., Doorduin, J., Elsinga, P. H., Dierckx, R. A. J. O., de Vries, E. F. J., & Casteels, C. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.05.066 · Cited by 19 · see citing works

Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine

Kodaka, F., Ito, H., Takano, H., Takahashi, H., Arakawa, R., Miyoshi, M., Okumura, M., Otsuka, T., Nakayama, K., Halldin, C., et al. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001148 · Cited by 19 · see citing works

Quantitative PET Analysis of the Dopamine D2 Receptor Agonist Radioligand 11C-(R)-2-CH3O-N-n-Propylnorapomorphine in the Human Brain

Otsuka, T., Ito, H., Halldin, C., Takahashi, H., Takano, H., Arakawa, R., Okumura, M., Kodaka, F., Miyoshi, M., Sekine, M., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058503 · Cited by 18 · see citing works

[11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors

Buiter, H. J. C., Windhorst, A. D., Huisman, M. C., Yaqub, M. M., Knol, D. L., Fisher, A., Lammertsma, A. A., & Leysen, J. E. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-19 · Cited by 18 · see citing works

GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain

Nikolaus, S., Wittsack, H.-J., Beu, M., Antke, C., Silva, M. A. D. S., Wickrath, F., Müller‐Lutz, A., Huston, J. P., Antoch, G., Müller, H.-W., et al. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00038 · Cited by 18 · see citing works

Estimation of D2-like Receptor Occupancy by Dopamine in the Putamen of Hemiparkinsonian Monkeys

Chefer, S. I., Kimes, A. S., Matochik, J. A., Horti, A. G., Kurian, V., Shumway, D. A., Domino, E. F., London, E. D., & Mukhin, A. G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301404 · Cited by 18 · see citing works

Serotonin concentration enhancers at clinically relevant doses reduce [11C]AZ10419369 binding to the 5-HT1B receptors in the nonhuman primate brain

Yang, K., Takano, A., Halldin, C., Farde, L., & Finnema, S. J. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0178-7 · Cited by 17 · see citing works

Amphetamine Decreases  2C-Adrenoceptor Binding of [11C]ORM-13070: A PET Study in the Primate Brain

Finnema, S. J., Hughes, Z. A., Haaparanta-Solin, M., Stepanov, V., Nakao, R., Varnas, K., Varrone, A., Arponen, E., Marjamaki, P., Pohjanoksa, K., et al. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu081 · Cited by 17 · see citing works

Estimating the effect of endogenous dopamine on baseline [11C]‐(+)‐PHNO binding in the human brain

Caravaggio, F., Kegeles, L. S., Wilson, A., Remington, G., Borlido, C., Mamo, D., & Graff-Guerrero, A. (2016) · Synapse · doi:10.1002/syn.21920 · Cited by 16 · see citing works

D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]‐MNPA, [3H]‐(+)‐PHNO, and [3H]‐raclopride

Peng, T., Zysk, J. R., Dorff, P. N., Elmore, C. S., Ström, P., Malmquist, J., Ding, M., Tuke, D., Werkheiser, J. L., Widzowski, D., et al. (2010) · Synapse · doi:10.1002/syn.20771 · Cited by 15 · see citing works

[18F]fallypride-PET/CT Analysis of the Dopamine D2/D3 Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection

Mann, T., Kurth, J., Hawlitschka, A., Stenzel, J., Lindner, T., Polei, S., Höhn, A., Krause, B. J., & Wree, A. (2018) · Molecules · doi:10.3390/molecules23030587 · Cited by 13 · see citing works

Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist

Xu, J., Vangveravong, S., Li, S., Fan, J., Jones, L. A., Cui, J., Wang, R., Tu, Z., Chu, W., Perlmutter, J. S., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.01.007 · Cited by 13 · see citing works

PET Imaging of Endocannabinoid System

Horti, A. G., Raymont, V., & Terry, G. E. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_11 · Cited by 11 · see citing works

Kinetic brain analysis and whole‐body imaging in monkey of [11C]MNPA: A dopamine agonist radioligand

Seneca, N. M., Skinbjerg, M., Zoghbi, S. S., Liow, J., Gladding, R. L., Hong, J. S., Kannan, P., Tuan, E. W., Sibley, D. R., Halldin, C., et al. (2008) · Synapse · doi:10.1002/syn.20544 · Cited by 11 · see citing works

Small Molecule Receptor Ligands for PET Studies of the Central Nervous System—Focus on G Protein Coupled Receptors

Mach, R. H. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.05.002 · Cited by 10 · see citing works

Synthesis and evaluation in rats of homologous series of [18F]-labeled dopamine D2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracers

Shalgunov, V., van Wieringen, J., Janssen, H. M., Fransen, P. M., Dierckx, R., Michel, M. C., Booij, J., & Elsinga, P. H. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0119-x · Cited by 10 · see citing works

A two‐step one‐pot radiosynthesis of the potent dopamine D2/D3 agonist PET radioligand [11C]MNPA

Steiger, C., Finnema, S. J., Raus, L., Schou, M., Nakao, R., Suzuki, K., Pike, V. W., Wikström, H., & Halldin, C. (2009) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1583 · Cited by 10 · see citing works

[ 11 C]AZ10419096 – a full antagonist PET radioligand for imaging brain 5-HT 1B receptors

Lindberg, A., Nag, S., Schou, M., Takano, A., Matsumoto, J., Amini, N., Elmore, C. S., Farde, L., Pike, V. W., & Halldin, C. (2017) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2017.07.007 · Cited by 9 · see citing works

Chapter 24 Discovery of Novel Positron Emission Tomography Tracers

McCarthy, D. J., Halldin, C., Andersson, J. D., & Pierson, M. E. (2009) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(09)04424-8 · Cited by 9 · see citing works

Radiosynthesis and biological evaluation of the M1 muscarinic acetylcholine receptor agonist ligand [11C]AF150(S)

Buiter, H. J. C., Leysen, J. E., Schuit, R. C., Fisher, A., Lammertsma, A. A., & Windhorst, A. D. (2012) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2932 · Cited by 9 · see citing works

Schizophrenia Diagnosis and Treatment

Seeman, P. M. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00250.x · Cited by 8 · see citing works

Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F]PSS232 in the Rat Brain

Herde, A. M., Boss, S. D., He, Y., Schibli, R., Mu, L., & Ametamey, S. M. (2018) · Pharmaceuticals · doi:10.3390/ph11030083 · Cited by 7 · see citing works

Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression

Visser, A. K. D., Ettrup, A., Klein, A. B., van Waarde, A., Bosker, F. J., Meerlo, P., Knudsen, G. M., & de Boer, S. F. (2015) · Synapse · doi:10.1002/syn.21810 · Cited by 6 · see citing works

Potential for imaging the high-affinity state of the 5-HT1B receptor: a comparison of three PET radioligands with differing intrinsic activity

Lindberg, A., Arakawa, R., Nogami, T., Nag, S., Schou, M., Elmore, C. S., Farde, L., Pike, V. W., & Halldin, C. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0570-1 · Cited by 6 · see citing works

Signal transduction pathway activity compensates dopamine D2/D3 receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [3H]raclopride and [35S]GTPγS

Farkas, S., Nagy, K., Jia, Z., Hortobágyi, T., Varrone, A., Halldin, C., Csiba, L., & Gulyás, B. Z. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.014 · Cited by 5 · see citing works

PET Imaging of the Endocannabinoid System

Terry, G. E., Raymont, V., & Horti, A. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_12 · Cited by 5 · see citing works

Agonist signalling properties of radiotracers used for imaging of dopamine D2/3 receptors

van Wieringen, J., Michel, M. C., Janssen, H. M., Janssen, A. G. M., Elsinga, P. H., & Booij, J. (2014) · EJNMMI Research · doi:10.1186/s13550-014-0053-3 · Cited by 4 · see citing works

Radiosynthesis and ex vivo evaluation of (R)-(−)-2-chloro-N-[1-11C-propyl]n-propylnorapomorphine

Palner, M., McCormick, P. N., Gillings, N., Begtrup, M., Wilson, A. A., & Knudsen, G. M. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.08.005 · Cited by 4 · see citing works

Dopamine Receptors and Dopamine Release

Kessler, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00012-9 · Cited by 1 · see citing works

Prolonged Amphetamine Exposures Increase the Endogenous Human Dopamine Receptors 2 at the Cellular Membrane in Cells Lacking the Dopamine Transporter

Nawaratne, V., McLaughlin, S. P., Mayer, F. P., Gichi, Z., Mastriano, A., & Carvelli, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.681539 · Cited by 3 · see citing works

Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA, a dopamine agonist radioligand

Seneca, N. M., Skinbjerg, M., Zoghbi, S. S., Liow, J., Gladding, R. L., Hong, J., Kannan, P., Tuan, E. W., Sibley, D. R., Halldin, C., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.107 · Cited by 3 · see citing works

In vivo imaging of the cannabinoid CB1 receptor using positron emission tomography

Terry, G. E. (2009) · Figshare · Cited by 3 · see citing works

GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the rat

Nikolaus, S., Beu, M., Wittsack, H., Müller‐Lutz, A., Antke, C., Hautzel, H., Mori, Y., Mamlins, E., Antoch, G., & Müller, H. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0112 · Cited by 2 · see citing works

1-Methyl-1,2,3,4-Tetrahydroisoquinoline: A Potent Neuroprotecting Agent

Vetulani, J., & Antkiewicz‐Michaluk, L. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1542-8_3 · Cited by 2 · see citing works

The synthesis of tritiated (R)‐2‐methoxy‐N‐n‐propyl‐nor‐apomorphine (MNPA)

Malmquist, J., Olofsson, S., & Ström, P. (2007) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1448 · Cited by 2 · see citing works

Effect of amphetamine dose on wheel-running functioning as reinforcement or operant behavior on a multiple schedule of reinforcement

Belke, T. W., Pierce, W. D., & Sexton, C. A. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000493 · Cited by 1 · see citing works

Dopamine D2 receptor pharmacology : In vitro analyses and in vivo pet imaging

Skinbjerg, M. (2009) · Figshare · Cited by 1 · see citing works

Brain PET Oral 4: in vivo Pharmacology I—Dopamine and Norepinephrine

(2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.124 · Cited by 1 · see citing works

SYNAPSE 59:260–269 (2006) Effect of Amphetamine on Dopamine D2 Receptor Binding in Nonhuman Primate Brain: A Comparison of the Agonist

Seneca, N., Finnema, S. J., Farde, L., Gulyás, B., Kan, H., Wikström, V., Halldin, C., & Innis, R. B. (2013)

A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.

Finnema, S., Seneca, N., Farde, L., Shchukin, E., Sóvágó, J., Gulyás, B., Wikström, H., Innis, R., Neumeyer, J., & Halldin, C. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.01.007 · Cited by 86 · see citing works

A Comparative Evaluation of the Dopamine D2/3 Agonist Radiotracer [11C](−)-N-Propyl-norapomorphine and Antagonist [11C]Raclopride to Measure Amphetamine-Induced Dopamine Release in the Human Striatum

Narendran, R., Mason, N. S., Laymon, C. M., Lopresti, B. J., Velasquez, N. D., May, M. A., Kendro, S., Martínez, D., Mathis, C. A., & Frankle, W. G. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163501 · Cited by 77 · see citing works

Dopamine D2/3receptor occupancy of apomorphine in the nonhuman primate brain—A comparative PET study with [11C]raclopride and [11C]MNPA

Finnema, S. J., Halldin, C., Bang‐Andersen, B., Gulyás, B. Z., Bundgaard, C., Wikström, H., & Farde, L. (2009) · Synapse · doi:10.1002/syn.20615 · Cited by 33 · see citing works

Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.

Ginovart, N., Wilson, A., Houle, S., & Kapur, S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.019 · Cited by 44 · see citing works